The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Главный автор: | Jackson, M |
---|---|
Другие авторы: | Vallis, K |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
2013
|
Предметы: |
Схожие документы
-
Selective targeting of homologous recombination deficiency
по: Zimmer, J
Опубликовано: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
по: Albukhari, A
Опубликовано: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
по: Albukhari, A
Опубликовано: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
по: Potter, M
Опубликовано: (2014) -
Radiopharmaceutical Validation for Clinical Use
по: Charles A. Kunos, и др.
Опубликовано: (2021-03-01)